Investing.com -- India and the United States are in advanced talks to address tariff imbalances, potentially reducing the threat of reciprocal tariffs on Indian imports, which have been a growing concern amid escalating trade tensions.
India’s high import duties, averaging 11.5% on goods, significantly exceed the 1.5% weighted average charged by the US. Sectors like agriculture, pharmaceuticals, and automobiles face the highest tariff differentials, making them focal points in the ongoing discussions.
Agriculture: India imposes a 40% effective tariff on US food products, compared to the US’s 6% duty on Indian imports. While reducing tariffs is politically sensitive given India’s large agricultural workforce, there is potential for increased market access for US exports of cotton, corn, and soybeans.
Pharmaceuticals: India exports low-cost generics to the US, which accounted for 15% of India’s exports to the US in 2024. Matching India’s 8-10% tariffs on pharmaceuticals could lead to generic drug shortages in the US, posing risks to affordability.
Automobiles: While India imposes tariffs of 5-15% on US auto components, US duties on Indian exports remain minimal. India’s plans to gradually reduce tariffs on electric vehicles could pave the way for increased US auto exports.
Energy and Textiles: Potential US sanctions on Venezuelan oil could marginally increase India’s import costs, while the textile sector, with comparable tariffs in both countries, faces less pressure.
Negotiations, which began on March 26, aim to finalize a deal by autumn, focusing primarily on reducing tariff and non-tariff barriers while keeping sensitive issues like immigration and IT services out of scope. India has already moved to eliminate a 6% equalization levy on digital ads, benefiting US tech firms.
A successful agreement could expand bilateral trade, enhance market access, and reduce uncertainties for both nations.
This content was originally published on Investing.com
